{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T09:40:49Z","timestamp":1778665249588,"version":"3.51.4"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsurgicalresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Surgical Research"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.jss.2020.12.045","type":"journal-article","created":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T21:36:07Z","timestamp":1611264967000},"page":"334-342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["HJC0416 Attenuates Fibrogenesis in Activated Hepatic Stellate Cells via STAT3 and NF-\u03baB Pathways"],"prefix":"10.1016","volume":"261","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3260-3370","authenticated-orcid":false,"given":"Christian","family":"Sommerhalder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire B.","family":"Cummins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divya","family":"Ramdas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar Nunez","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanping","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi S.","family":"Radhakrishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jss.2020.12.045_bib1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bpg.2011.02.005","article-title":"Mechanisms of hepatic fibrogenesis","volume":"25","author":"Lee","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.jss.2020.12.045_bib2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12916-014-0159-5","article-title":"The global burden of liver disease: a challenge for methods and for public health","volume":"12","author":"Byass","year":"2014","journal-title":"BMC Med"},{"key":"10.1016\/j.jss.2020.12.045_bib3","first-page":"1075","article-title":"Liver fibrosis: a dynamic and potentially reversible process","volume":"25","author":"Povero","year":"2010","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.jss.2020.12.045_bib4","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jss.2018.06.040","article-title":"Antifibrosis effect of novel oridonin analog CYD0618 via suppression of the NF-kappaB pathway","volume":"232","author":"Cummins","year":"2018","journal-title":"J Surg Res"},{"key":"10.1016\/j.jss.2020.12.045_bib5","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1172\/JCI66028","article-title":"Evolving therapies for liver fibrosis","volume":"123","author":"Schuppan","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jss.2020.12.045_bib6","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature10237","article-title":"HIV-1 adaptation to NK-cell-mediated immune pressure","volume":"476","author":"Alter","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jss.2020.12.045_bib7","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.bbadis.2013.02.019","article-title":"Origins and functions of liver myofibroblasts","volume":"1832","author":"Lemoinne","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jss.2020.12.045_bib8","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jhep.2010.11.035","article-title":"Inhibition of PDGF, TGF-beta, and Abl signaling and reduction of liver fibrosis by the small molecule Bcr-Abl tyrosine kinase antagonist Nilotinib","volume":"55","author":"Liu","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jss.2020.12.045_bib9","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1016\/j.bcp.2004.08.022","article-title":"Effects and regulation of osteopontin in rat hepatic stellate cells","volume":"68","author":"Lee","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jss.2020.12.045_bib10","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/hep.22637","article-title":"Fibrogenesis in pediatric cholestatic liver disease: role of taurocholate and hepatocyte-derived monocyte chemotaxis protein-1 in hepatic stellate cell recruitment","volume":"49","author":"Ramm","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jss.2020.12.045_bib11","doi-asserted-by":"crossref","first-page":"e0174374","DOI":"10.1371\/journal.pone.0174374","article-title":"Downregulation of UBC9 promotes apoptosis of activated human LX-2 hepatic stellate cells by suppressing the canonical NF-kappaB signaling pathway","volume":"12","author":"Fang","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jss.2020.12.045_bib12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jhep.2009.03.024","article-title":"Apoptotic body engulfment by hepatic stellate cells promotes their survival by the JAK\/STAT and Akt\/NF-kappaB-dependent pathways","volume":"51","author":"Jiang","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jss.2020.12.045_bib13","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1089\/ars.2010.3848","article-title":"Adipokines and redox signaling: impact on fatty liver disease","volume":"15","author":"Parola","year":"2011","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.jss.2020.12.045_bib14","doi-asserted-by":"crossref","first-page":"7243","DOI":"10.1073\/pnas.1507499112","article-title":"Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition","volume":"112","author":"Su","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jss.2020.12.045_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19061567","article-title":"Luteolin-Mediated inhibition of hepatic stellate cell activation via suppression of the STAT3 pathway","volume":"19","author":"Cummins","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jss.2020.12.045_bib16","doi-asserted-by":"crossref","first-page":"100652","DOI":"10.1039\/C6RA17459K","article-title":"STAT3 inhibition suppresses hepatic stellate cell fibrogenesis: HJC0123, a potential therapeutic agent for liver fibrosis","volume":"6","author":"Nunez Lopez","year":"2016","journal-title":"RSC Adv"},{"issue":"5","key":"10.1016\/j.jss.2020.12.045_bib17","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s10495-005-1055-4","article-title":"The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis","volume":"10","author":"Elsharkawy","year":"2005","journal-title":"Apoptosis"},{"key":"10.1016\/j.jss.2020.12.045_bib18","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.cbpa.2011.05.008","article-title":"Molecular complexity and fragment-based drug discovery: ten years on","volume":"15","author":"Leach","year":"2011","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.jss.2020.12.045_bib19","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.copbio.2006.10.007","article-title":"Fragment-based lead discovery: a chemical update","volume":"17","author":"Erlanson","year":"2006","journal-title":"Curr Opin Biotechnol"},{"key":"10.1016\/j.jss.2020.12.045_bib20","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ejmech.2013.01.023","article-title":"Fragment-based drug design and identification of HJC0123, a novel orally bioavailable STAT3 inhibitor for cancer therapy","volume":"62","author":"Chen","year":"2013","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.jss.2020.12.045_bib21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ejmech.2014.05.049","article-title":"Discovery of potent anticancer agent HJC0416, an orally bioavailable small molecule inhibitor of signal transducer and activator of transcription 3 (STAT3)","volume":"82","author":"Chen","year":"2014","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.jss.2020.12.045_bib22","doi-asserted-by":"crossref","first-page":"6857","DOI":"10.2147\/CMAR.S188364","article-title":"HJC0152, a novel STAT3 inhibitor with promising anti-tumor effect in gastric cancer","volume":"10","author":"Jiang","year":"2018","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.jss.2020.12.045_bib23","doi-asserted-by":"crossref","first-page":"e12777","DOI":"10.1111\/cpr.12777","article-title":"HJC0152 suppresses human non-small-cell lung cancer by inhibiting STAT3 and modulating metabolism","author":"Lu","year":"2020","journal-title":"Cell Prolif"},{"key":"10.1016\/j.jss.2020.12.045_bib24","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.matbio.2017.11.011","article-title":"Matrix metalloproteinase functions in hepatic injury and fibrosis","volume":"68","author":"Roderfeld","year":"2018","journal-title":"Matrix Biol"},{"key":"10.1016\/j.jss.2020.12.045_bib25","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1053\/jhep.2003.50097","article-title":"Replicative senescence of activated human hepatic stellate cells is accompanied by a pronounced inflammatory but less fibrogenic phenotype","volume":"37","author":"Schnabl","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jss.2020.12.045_bib26","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cell.2008.06.049","article-title":"Senescence of activated stellate cells limits liver fibrosis","volume":"134","author":"Krizhanovsky","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.jss.2020.12.045_bib27","first-page":"225","article-title":"Activated hepatic stellate cells in liver cirrhosis. A morphologic and morphometrical study","volume":"109","author":"Carpino","year":"2004","journal-title":"Ital J Anat Embryol"},{"key":"10.1016\/j.jss.2020.12.045_bib28","doi-asserted-by":"crossref","first-page":"e0176173","DOI":"10.1371\/journal.pone.0176173","article-title":"Both MAPK and STAT3 signal transduction pathways are necessary for IL-6-dependent hepatic stellate cells activation","volume":"12","author":"Kagan","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jss.2020.12.045_bib29","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1136\/gutjnl-2016-313392","article-title":"The HLF\/IL-6\/STAT3 feedforward circuit drives hepatic stellate cell activation to promote liver fibrosis","volume":"67","author":"Xiang","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jss.2020.12.045_bib30","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1111\/febs.13285","article-title":"STAT3 the oncogene - still eluding therapy?","volume":"282","author":"Wake","year":"2015","journal-title":"FEBS J"},{"key":"10.1016\/j.jss.2020.12.045_bib31","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.4049\/jimmunol.1401779","article-title":"Noncanonical STAT3 activation regulates excess TGF-beta1 and collagen I expression in muscle of stricturing Crohn's disease","volume":"194","author":"Li","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.jss.2020.12.045_bib32","doi-asserted-by":"crossref","first-page":"34958","DOI":"10.1074\/jbc.M704548200","article-title":"Stat3 isoforms, alpha and beta, demonstrate distinct intracellular dynamics with prolonged nuclear retention of Stat3beta mapping to its unique C-terminal end","volume":"282","author":"Huang","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jss.2020.12.045_bib33","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.3892\/ijo.2014.2259","article-title":"The IL-6\/JAK\/STAT3 pathway: potential therapeutic strategies in treating colorectal cancer (Review)","volume":"44","author":"Wang","year":"2014","journal-title":"Int J Oncol"},{"key":"10.1016\/j.jss.2020.12.045_bib34","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejphar.2014.11.040","article-title":"The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0\/G1 phase cell cycle arrest: persistent p27(Kip1) induction by interfering with PI3K\/Akt\/FOXO3a signaling pathway","volume":"747","author":"Li","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jss.2020.12.045_bib35","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/hep.28456","article-title":"Interleukin-1 and inflammasomes in alcoholic liver disease\/acute alcoholic hepatitis and nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"64","author":"Tilg","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jss.2020.12.045_bib36","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jhep.2011.01.048","article-title":"Lack of interleukin-1alpha or interleukin-1beta inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice","volume":"55","author":"Kamari","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jss.2020.12.045_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20061295","article-title":"Interleukin-1 receptor antagonist modulates liver inflammation and fibrosis in mice in a model-dependent manner","volume":"20","author":"Meier","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jss.2020.12.045_bib38","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/hep.510240333","article-title":"Expression of intracellular adhesion molecule 1 by activated hepatic stellate cells","volume":"24","author":"Hellerbrand","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.jss.2020.12.045_bib39","doi-asserted-by":"crossref","first-page":"55633","DOI":"10.1074\/jbc.M409825200","volume":"279","author":"Buss","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jss.2020.12.045_bib40","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1074\/jbc.M112.385625","article-title":"Site-specific phosphorylation of the p65 protein subunit mediates selective gene expression by differential NF-kappaB and RNA polymerase II promoter recruitment","volume":"288","author":"Hochrainer","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jss.2020.12.045_bib41","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/hep.25744","article-title":"Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis","volume":"56","author":"Kong","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jss.2020.12.045_bib42","first-page":"361","article-title":"Neutrophil-derived superoxide anion induces lipid peroxidation and stimulates collagen synthesis in human hepatic stellate cells: role of nitric oxide","volume":"25","author":"Casini","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jss.2020.12.045_bib43","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/hep.20051","article-title":"Apoptosis: the nexus of liver injury and fibrosis","volume":"39","author":"Canbay","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jss.2020.12.045_bib44","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1055\/s-2001-17555","article-title":"Interactions between hepatic stellate cells and the immune system","volume":"21","author":"Maher","year":"2001","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jss.2020.12.045_bib45","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrgastro.2010.213","article-title":"NF- \u03baB in the liver-linking injury, fibrosis and hepatocellular carcinoma","volume":"8","author":"Luedde","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jss.2020.12.045_bib46","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ccr.2009.01.009","article-title":"Inflammation and cancer: IL-6 and STAT3 complete the link","volume":"15","author":"Bromberg","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jss.2020.12.045_bib47","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.molmed.2007.12.007","article-title":"The wolf in sheep\u2019s clothing: the role of interleukin-6 on immunity, inflammation and cancer","volume":"14","author":"Naugler","year":"2008","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.jss.2020.12.045_bib48","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.molcel.2010.07.023","article-title":"STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer","volume":"39","author":"Iliopoulos","year":"2010","journal-title":"Mol Cell"}],"container-title":["Journal of Surgical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480420309069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480420309069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T14:52:38Z","timestamp":1758379958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022480420309069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":48,"alternative-id":["S0022480420309069"],"URL":"https:\/\/doi.org\/10.1016\/j.jss.2020.12.045","relation":{},"ISSN":["0022-4804"],"issn-type":[{"value":"0022-4804","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HJC0416 Attenuates Fibrogenesis in Activated Hepatic Stellate Cells via STAT3 and NF-\u03baB Pathways","name":"articletitle","label":"Article Title"},{"value":"Journal of Surgical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jss.2020.12.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}